| UHC Surest Medical and Drug | Surgery of the Ankle – Commercial and Individual Exchange Medical Policy | 2026-07-01 |
| UHC Surest Medical and Drug | Ustekinumab – Commercial Medical Benefit Drug Policy | 2026-07-01 |
| BCBS Florida Coverage Guidelines | 09-J9000-01 | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Abatacept (Orencia®) Injection and Infusion (09-J0000-67) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Abrocitinib (Cibinqo®) Tablets (09-J4000-27) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Agalsidase Beta (Fabrazyme®) IV (09-J2000-59) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Alpha1-Proteinase Inhibitors (Human) (09-J0000-49) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Amivantamab-vmjw (Rybrevant™), (09-J4000-02) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Anakinra (Kineret®) Injection (09-J0000-45) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Apremilast (Otezla, Otezla XR) Tablet (09-J2000-19) | 2026-07-01 |